Dentium (A145720) Q3 2025 earnings summary

Executive summary

• Revenue for 2025 Q3 was KRW 237.3 billion, a 17% decrease year-over-year due to weak sales in China and domestic markets amid economic downturn and intensified competition.

• Operating income dropped to KRW 37.6 billion, reflecting reduced sales leverage and higher cost ratios.

• Net income attributable to controlling interests fell to KRW 21.4 billion, impacted by one-time overseas subsidiary tax expenses.

• Focus remains on dental implant products, with 88% of sales from implants and 80% of revenue from overseas markets.

• Expanded business portfolio to include hydrogen fuel cell energy, with new production facilities in Vietnam targeting SOFC technology.

Financial highlights

• Gross margin declined to 62.8% from 68.7% year-over-year.

• Operating margin decreased to 15.9% from 25.7% year-over-year.

• SG&A expenses fell 10% year-over-year, with advertising expenses down 57%.

• EBITDA for the quarter was KRW 18.6 billion, down year-over-year.

• Basic EPS for 2025 Q3: KRW 2,480, compared to KRW 8,431 in 2024.

Outlook and guidance

• Ongoing economic weakness in China and domestic markets expected to continue affecting demand.

• Hydrogen fuel cell business expected to begin production and sales after 2026, leveraging zirconia expertise.

• Dental segment to focus on digital dentistry and global expansion, especially in high-growth markets like China.

• Anticipates gradual sales recovery in Korea by 2026 and continued growth in Vietnam and Thailand.

• Plans to strengthen localization strategies in China and expand supply chain operations.